糖尿病视网膜病变：治疗进展。

Diabetic retinopathy: An update on treatment.

机构信息

University of Colorado School of Medicine, Denver, 80045, USA.

出版信息

Am J Med. 2010 Mar;123(3):213-6. doi: 10.1016/j.amjmed.2009.09.020.

DOI:10.1016/j.amjmed.2009.09.020

PMID:20193825

Abstract

Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.

摘要

糖尿病性视网膜病变是一种进行性疾病，由慢性高血糖引起的血管损伤所致。它是美国导致工作年龄成年人失明的主要原因，通常在晚期才出现症状。激光光凝治疗对于预防严重视力丧失是有效的；因此，糖尿病患者应定期由眼科医生进行筛查。血管内皮生长因子的新抑制剂可能提供有针对性的非手术治疗，以改善糖尿病性视网膜病变的视力。